APA استشهاد

Brady, A. K., McNeill, J. D., Judy, B., Bauml, J., Evans, T. L., Cohen, R. B., . . . Aggarwal, C. (2015). Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy. Oncotarget.

استشهاد بنمط شيكاغو

Brady, Anna K., Jonathan D. McNeill, Brendan Judy, Joshua Bauml, Tracey L. Evans, Roger B. Cohen, Corey Langer, Anil Vachani, و Charu Aggarwal. "Survival Outcome According to KRAS Mutation Status in Newly Diagnosed Patients With Stage IV Non-small Cell Lung Cancer Treated With Platinum Doublet Chemotherapy." Oncotarget 2015.

MLA استشهاد

Brady, Anna K., et al. "Survival Outcome According to KRAS Mutation Status in Newly Diagnosed Patients With Stage IV Non-small Cell Lung Cancer Treated With Platinum Doublet Chemotherapy." Oncotarget 2015.

تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.